Bedside Renal Ultrasound Assessment in Patients With Acute Kidney Injury

Recruiting

• Conditions: Critical Illness

• Registration Number: NCT06156098
• Lead Sponsor: Qin Zhang

Brief Summary

Exploring the predictive and evaluative value of various indicators of bedside critical renal ultrasound in critically ill patients with acute kidney injury (AKI)

Detailed Description

This study aims to perform bedside renal ultrasound examinations on critically ill patients admitted to the ICU (including sepsis, respiratory failure, shock, multiple trauma, etc.) and prospectively observe the relationship between ultrasound parameters and the occurrence and progression of AKI, in conjunction with traditional renal function indicators. This will provide clinicians with a rapid, non-invasive, and visual examination tool at the bedside for early diagnosis and treatment of AKI.

Study Timeline

• Study Start: 2023-09-01
• Study First Submitted: 2023-10-06
• Primary Completion: 2023-11-30
• Study First Submitted QC: 2023-12-03
• Study First Posted: 2023-12-05
• Status Verified: 2024-04
• Last Update Submitted: 2024-04-08
• Last Update Posted: 2024-04-10
• Study Completion: 2024-09-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Age ≥ 18 years and ≤ 70 years
• Criteria for sepsis patients

Exclusion Criteria

• Pregnant women.
• Patients with malignant tumors, severe heart failure, chronic renal insufficiency, end stage renal disease, kidney transplantation.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Survival	28 days	28-day mortality rate

Secondary Outcome Measures

Name	Time	Method
AKI	28 days	duration of continuous renal replacement therapy (CRRT)during hospitalization, length of hospital stay, duration of ICU stay, hospital mortality rate, 28-day mortality rate, and other relevant data.

Trial Locations

Locations (1)

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; 🇨🇳 Wuhan, Hubei, China